More cancer survivors speak up about Proleukin® Interleukin-2 (IL-2)

Stan

Stan's Story

This is the story of Stan, a metastatic melanoma patient who really did his homework: For a week after he was diagnosed, Stan locked himself in his office and spent countless hours "looking at what my possible treatment options were."

Watch Stan's story

X

Stan's Story

Gary and Linda

Gary and Linda's story

In 2003, Gary was diagnosed with metastatic melanoma. "It was the shocker of my life," he said. His wife Linda said, "It hits you like a brick, and you don't know what to do." See what Gary and Linda went through and what they learned along the way.

Watch Gary and Linda's story

X

Gary and Linda's story

Mark

Mark's story

Mark had 14 tumors when he was diagnosed with metastatic melanoma. Find out what happened next, why he chose Proleukin, and where Mark is today.

Watch Mark's story

X

Mark's story

Karen and Sterling

Karen and Sterling's story

When Karen was diagnosed with metastatic melanoma, Sterling began to search the internet to understand their treatment options. "It's a daunting task," he said, "because there's a lot of different voices out there." Learn what Karen and Sterling decided was their best course of action.

Watch Karen and Sterling's story

X

Karen and Sterling's story

Jill

Jill's story

How were you diagnosed? Jill had tremendous pain in her side, which turned out to be a tumor, leading to her diagnosis of metastatic melanoma. Jill's sister Robin helped her get through it all. "IL was the hardest thing I've ever done, but I'm alive. I'm here," Jill said.

Watch Jill's story

X

Jill's story

In Proleukin clinical studies, about 1 in 17 patients with metastatic melanoma had no evidence of disease ranging from
3 months to 10+ years.

We also invite you to:

How to discuss Proleukin with your doctor

aThe experience of these patients isn't representative of overall results with Proleukin.